Changes in serum and urine amino acids in patients with progressive systemic sclerosis treated with 6-azauridine triacetate.
D000328:Adult; D000409:Alanine / Q000652:urine; D000596:Amino Acids / Q000097:blood / Q000378:metabolism* / Q000652:urine; D000613:Aminobutyrates / Q000652:urine; D001380:Azauridine / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006711:Homocystine / Q000097:blood / Q000652:urine; D006801:Humans; D008875:Middle Aged; D012595:Scleroderma, Systemic / Q000097:blood / Q000188:drug therapy / Q000378:metabolism* / Q000652:urine; D013997:Time Factors
D000596:Amino Acids; D000613:Aminobutyrates; D006711:Homocystine; D001380:Azauridine; D000409:Alanine